Innovation mot infektion - Creative Antibiotics Sweden AB
Innovation mot infektion - Creative Antibiotics Sweden AB
Innovation mot infektion - Creative Antibiotics Sweden AB
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Bolagsanalys<br />
57<br />
<strong>Creative</strong> <strong>Antibiotics</strong><br />
Viktiga händelser inom antibiotikaområdet 2004-2017<br />
2004-2008 Ciproxin, 2004 Tazocin, 2007 Spectracef, 2004<br />
Zosyn, 2007<br />
Zithromax, 2005<br />
Biaxin, 2005<br />
2009 Vibativ Merrem<br />
2010 Merrem<br />
Zeftera Zeftera Tygacil<br />
2011 Levaquin Tavanic Cravit, Merrem<br />
Ceftaroline Vibativ, Ceftaroline<br />
2012 Doribax Tygacil<br />
2013 Zeftera<br />
2014 Avelox Avelox Avelox<br />
2015 Zyvox Vibativ<br />
2016 Tygacil Zyvox<br />
2017 Tygacil<br />
Lansering<br />
Patentutgång<br />
Källa: Redeye Research, Datamonitor<br />
Andel patentskyddade – och generisk antibiotika 2008-<br />
2019<br />
100%<br />
90%<br />
80%<br />
70%<br />
60%<br />
50%<br />
40%<br />
30%<br />
20%<br />
10%<br />
0%<br />
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019<br />
Källa: Redeye Research, Datamonitor<br />
Generika Patent
Change language